| Year |
Citation |
Score |
| 2023 |
Bononi A, Wang Q, Zolondick AA, Bai F, Steele-Tanji M, Suarez JS, Pastorino S, Sipes A, Signorato V, Ferro A, Novelli F, Kim JH, Minaai M, Takinishi Y, Pellegrini L, et al. BAP1 is a novel regulator of HIF-1α. Proceedings of the National Academy of Sciences of the United States of America. 120: e2217840120. PMID 36656861 DOI: 10.1073/pnas.2217840120 |
0.4 |
|
| 2022 |
Karmi O, Marjault HB, Bai F, Roy S, Sohn YS, Darash Yahana M, Morcos F, Ioannidis K, Nahmias Y, Jennings PA, Mittler R, Onuchic JN, Nechushtai R. A VDAC1-mediated NEET protein chain transfers [2Fe-2S] clusters between the mitochondria and the cytosol and impacts mitochondrial dynamics. Proceedings of the National Academy of Sciences of the United States of America. 119. PMID 35135884 DOI: 10.1073/pnas.2121491119 |
0.479 |
|
| 2021 |
Novelli F, Bononi A, Wang Q, Bai F, Patergnani S, Kricek F, Haglund E, Suarez JS, Tanji M, Xu R, Takanishi Y, Minaai M, Pastorino S, Morris P, Sakamoto G, et al. BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene × environment interaction with asbestos. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34815344 DOI: 10.1073/pnas.2111946118 |
0.441 |
|
| 2021 |
Chen J, Wang Z, Gao S, Wu K, Bai F, Zhang Q, Wang H, Ye Q, Xu F, Sun H, Lu Y, Liu Y. Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer. Cancer Cell International. 21: 183. PMID 33765996 DOI: 10.1186/s12935-021-01876-1 |
0.391 |
|
| 2021 |
Chen J, Wang Z, Gao S, Wu K, Bai F, Zhang Q, Wang H, Ye Q, Xu F, Sun H, Lu Y, Liu Y. Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer. Cancer Cell International. 21: 136. PMID 33632224 DOI: 10.1186/s12935-021-01842-x |
0.414 |
|
| 2020 |
Guo WH, Qi X, Yu X, Liu Y, Chung CI, Bai F, Lin X, Lu D, Wang L, Chen J, Su LH, Nomie KJ, Li F, Wang MC, Shu X, et al. Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry. Nature Communications. 11: 4268. PMID 32848159 DOI: 10.1038/S41467-020-17997-6 |
0.636 |
|
| 2019 |
Lipper CH, Stofleth JT, Bai F, Sohn YS, Roy S, Mittler R, Nechushtai R, Onuchic JN, Jennings PA. Redox-dependent gating of VDAC by mitoNEET. Proceedings of the National Academy of Sciences of the United States of America. PMID 31527235 DOI: 10.1073/Pnas.1908271116 |
0.513 |
|
| 2019 |
Iosub-Amir A, Bai F, Sohn YS, Song L, Tamir S, Marjault HB, Mayer G, Karmi O, Jennings PA, Mittler R, Onuchic JN, Friedler A, Nechushtai R. The anti-apoptotic proteins NAF-1 and iASPP interact to drive apoptosis in cancer cells. Chemical Science. 10: 665-673. PMID 30774867 DOI: 10.1039/C8Sc03390K |
0.494 |
|
| 2018 |
Tan Z, Xiao L, Tang M, Bai F, Li J, Li L, Shi F, Li N, Li Y, Du Q, Lu J, Weng X, Yi W, Zhang H, Fan J, et al. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy. Theranostics. 8: 2329-2347. PMID 29721083 DOI: 10.7150/Thno.21451 |
0.454 |
|
| 2018 |
Mittler R, Darash-Yahana M, Sohn YS, Bai F, Song L, Cabantchik IZ, Jennings P, Onuchic J, Nechushtai R. NEET proteins: A new link between iron metabolism, ROS and cancer. Antioxidants & Redox Signaling. PMID 29463105 DOI: 10.1089/Ars.2018.7502 |
0.497 |
|
| 2017 |
Karmi O, Holt SH, Song L, Tamir S, Luo Y, Bai F, Adenwalla A, Darash-Yahana M, Sohn YS, Jennings PA, Azad RK, Onuchic JN, Morcos F, Nechushtai R, Mittler R. Interactions between mitoNEET and NAF-1 in cells. Plos One. 12: e0175796. PMID 28426722 DOI: 10.1371/Journal.Pone.0175796 |
0.489 |
|
| 2016 |
Bai F, Morcos F, Cheng RR, Jiang H, Onuchic JN. Elucidating the druggable interface of protein-protein interactions using fragment docking and coevolutionary analysis. Proceedings of the National Academy of Sciences of the United States of America. PMID 27911825 DOI: 10.1073/Pnas.1615932113 |
0.652 |
|
| 2016 |
Darash-Yahana M, Pozniak Y, Lu M, Sohn YS, Karmi O, Tamir S, Bai F, Song L, Jennings PA, Pikarsky E, Geiger T, Onuchic JN, Mittler R, Nechushtai R. Breast cancer tumorigenicity is dependent on high expression levels of NAF-1 and the lability of its Fe-S clusters. Proceedings of the National Academy of Sciences of the United States of America. PMID 27621439 DOI: 10.1073/Pnas.1612736113 |
0.495 |
|
| 2016 |
Yim KH, Prince TL, Qu S, Bai F, Jennings PA, Onuchic JN, Theodorakis EA, Neckers L. Gambogic acid identifies an isoform-specific druggable pocket in the middle domain of Hsp90β. Proceedings of the National Academy of Sciences of the United States of America. PMID 27466407 DOI: 10.1073/Pnas.1606655113 |
0.487 |
|
| 2015 |
Bai F, Morcos F, Sohn YS, Darash-Yahana M, Rezende CO, Lipper CH, Paddock ML, Song L, Luo Y, Holt SH, Tamir S, Theodorakis EA, Jennings PA, Onuchic JN, Mittler R, et al. The Fe-S cluster-containing NEET proteins mitoNEET and NAF-1 as chemotherapeutic targets in breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 112: 3698-703. PMID 25762074 DOI: 10.1073/Pnas.1502960112 |
0.536 |
|
| 2013 |
Bai F, Xu Y, Chen J, Liu Q, Gu J, Wang X, Ma J, Li H, Onuchic JN, Jiang H. Free energy landscape for the binding process of Huperzine A to acetylcholinesterase. Proceedings of the National Academy of Sciences of the United States of America. 110: 4273-8. PMID 23440190 DOI: 10.1073/Pnas.1301814110 |
0.458 |
|
| Show low-probability matches. |